Teladoc Health Inc
General ticker "TDOC" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $1.8B
Teladoc Health Inc does not follow the US Stock Market performance with the rate: -25.4%.
Estimated limits based on current volatility of 4.5%: low 9.07$, high 9.93$
Factors to consider:
- US accounted for 86.0% of revenue in the fiscal year ended 2023-12-31
- Current price 39.4% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [15.57$, 33.41$]
- 2024-12-30 to 2025-12-30 estimated range: [15.79$, 33.11$]
Financial Metrics affecting the TDOC estimates:
- Negative: Non-GAAP EPS, $ of -1.29 <= 0.10
- Negative: Operating profit margin, % of -8.72 <= 1.03
- Positive: -3.48 < Investing cash flow per share, $ of -0.96
- Negative: negative Net income
Short-term TDOC quotes
Long-term TDOC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,032.71MM | $2,406.84MM | $2,602.41MM |
| Operating Expenses | $2,298.34MM | $16,060.05MM | $2,850.97MM |
| Operating Income | $-265.63MM | $-13,653.21MM | $-248.55MM |
| Non-Operating Income | $-119.03MM | $-10.13MM | $28.95MM |
| Interest Expense | $80.36MM | $9.27MM | $22.28MM |
| R&D Expense | $311.88MM | $333.63MM | $348.52MM |
| Income(Loss) | $-384.66MM | $-13,663.34MM | $-219.61MM |
| Taxes | $44.14MM | $-3.81MM | $0.76MM |
| Profit(Loss) | $-428.79MM | $-13,659.53MM | $-220.37MM |
| Stockholders Equity | $16,045.76MM | $2,307.74MM | $2,326.07MM |
| Inventory | $73.08MM | $56.34MM | $29.51MM |
| Assets | $17,734.61MM | $4,345.35MM | $4,392.37MM |
| Operating Cash Flow | $193.99MM | $189.29MM | $350.02MM |
| Capital expenditure | $63.93MM | $172.76MM | $156.35MM |
| Investing Cash Flow | $-72.98MM | $-167.74MM | $-156.35MM |
| Financing Cash Flow | $40.95MM | $6.50MM | $10.85MM |
| Earnings Per Share* | $-2.73 | $-84.60 | $-1.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.